US: Bromazolam Prevalence Surgining Across the United States

NPS Discovery would like to notify you about new information regarding the new benzodiazepine Bromazolam. Identifications for this benzodiazepine are increasing based on our data from comprehensive toxicology testing of authentic biological samples, driven in part by increasing detections alongside the synthetic opioid fentanyl. Bromazolam has been identified in more than 250 forensic cases originating from various states and regions across the United States. It should be noted that bromazolam is not widely incorporated into forensic testing workflows and could be missed during standard toxicological investigations. This new Public Alert details our results and recommendations to help our collaborative communities combat this new drug.

Full Report